A detailed history of Morgan Stanley transactions in Celcuity Inc. stock. As of the latest transaction made, Morgan Stanley holds 1,392,705 shares of CELC stock, worth $17.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,392,705
Previous 2,835,465 50.88%
Holding current value
$17.5 Million
Previous $46.4 Million 55.29%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$13.98 - $19.15 $20.2 Million - $27.6 Million
-1,442,760 Reduced 50.88%
1,392,705 $20.8 Million
Q2 2024

Oct 17, 2024

BUY
$14.1 - $20.78 $6.85 Million - $10.1 Million
486,120 Added 20.69%
2,835,465 $46.4 Million
Q2 2024

Aug 14, 2024

BUY
$14.1 - $20.78 $6.85 Million - $10.1 Million
486,120 Added 20.69%
2,835,465 $46.4 Million
Q1 2024

Oct 17, 2024

SELL
$13.74 - $21.6 $6.68 Million - $10.5 Million
-486,120 Reduced 17.14%
2,349,345 $50.7 Million
Q1 2024

Aug 16, 2024

BUY
$13.74 - $21.6 $2.12 Million - $3.33 Million
154,166 Added 7.02%
2,349,345 $50.7 Million
Q1 2024

May 15, 2024

BUY
$13.74 - $21.6 $2.12 Million - $3.33 Million
154,166 Added 7.02%
2,349,345 $50.7 Million
Q4 2023

Aug 16, 2024

SELL
$8.7 - $15.02 $5.57 Million - $9.62 Million
-640,286 Reduced 22.58%
2,195,179 $32 Million
Q4 2023

Feb 13, 2024

BUY
$8.7 - $15.02 $1.98 Million - $3.42 Million
227,403 Added 11.56%
2,195,179 $32 Million
Q3 2023

Nov 15, 2023

BUY
$8.96 - $10.75 $3.35 Million - $4.02 Million
374,196 Added 23.48%
1,967,776 $18 Million
Q2 2023

Aug 14, 2023

BUY
$9.39 - $12.18 $2.53 Million - $3.28 Million
269,067 Added 20.31%
1,593,580 $17.5 Million
Q1 2023

May 15, 2023

BUY
$9.4 - $12.82 $2.19 Million - $2.98 Million
232,672 Added 21.31%
1,324,513 $13.6 Million
Q4 2022

Feb 14, 2023

BUY
$7.55 - $14.01 $422,792 - $784,545
55,999 Added 5.41%
1,091,841 $15.3 Million
Q3 2022

Nov 14, 2022

BUY
$8.0 - $10.64 $6.18 Million - $8.21 Million
771,918 Added 292.48%
1,035,842 $10.4 Million
Q2 2022

Oct 27, 2022

BUY
$5.35 - $10.11 $1.31 Million - $2.47 Million
244,563 Added 1263.17%
263,924 $2.4 Million
Q2 2022

Aug 15, 2022

BUY
$5.35 - $10.11 $1.31 Million - $2.47 Million
244,563 Added 1263.17%
263,924 $2.4 Million
Q1 2022

Oct 27, 2022

SELL
$7.93 - $13.33 $1.94 Million - $3.26 Million
-244,563 Reduced 92.66%
19,361 $182,000
Q1 2022

May 13, 2022

BUY
$7.93 - $13.33 $50,712 - $85,245
6,395 Added 49.32%
19,361 $182,000
Q4 2021

Feb 14, 2022

BUY
$11.96 - $19.35 $16,468 - $26,644
1,377 Added 11.88%
12,966 $171,000
Q3 2021

Nov 15, 2021

BUY
$17.35 - $24.87 $201,069 - $288,218
11,589 New
11,589 $207,000

Others Institutions Holding CELC

About Celcuity Inc.


  • Ticker CELC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,941,300
  • Market Cap $187M
  • Description
  • Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...
More about CELC
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.